PAION AG AACHEN ORDINARY SHARES GERMANY (OTCMKTS:PAIOF) on Focus After Report of More Shorts

October 11, 2018 - By Jack Shaw

The stock of PAION AG AACHEN ORDINARY SHARES GERMANY (OTCMKTS:PAIOF) registered an increase of 0.55% in short interest. PAIOF’s total short interest was 109,900 shares in October as published by FINRA. Its up 0.55% from 109,300 shares, reported previously. With 300 shares average volume, it will take short sellers 366 days to cover their PAIOF’s short positions.

It closed at $2.65 lastly. It is down 0.00% since October 11, 2017 and is . It has underperformed by 15.62% the S&P500.

PAION AG, a specialty pharmaceutical company, develops and commercializes drugs for use in out-patient and hospital sedation, anesthesia, and critical care services worldwide. The company has market cap of $174.08 million. The companyÂ’s lead product is Remimazolam, an intravenous ultra-short-acting anesthetic, which is in Phase III clinical development stage for use in procedural sedation, as well as in other indications, such as general anesthesia and intensive care unit sedation. It currently has negative earnings. It has partnerships and license agreements with Cosmo Pharmaceuticals, Yichang Humanwell, R-Pharm, TR-Pharm, and Hana Pharm.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: